文献速递腹部技术与安全PETCT

基于18F-FDG PET/CT影像组学列线图预测II/III期结直肠腺癌无病生存

A 18F-FDG PET/CT based radiomics nomogram for predicting disease-free survival in stage II/III colorectal adenocarcinoma.
PubMed 文献 · Abdom Radiol (NY) · 2024-08-03

本研究回顾性纳入2011年7月至2021年7月中山大学附属第六医院的332例II/III期结直肠腺癌患者,利用18F-FDG PET/CT提取影像组学特征并结合临床病理参数构建列线图预测无病生存;列线图包含Rad-score、pN和pT,训练队列1、2、3年AUC分别为0.78、0.80、0.86,验证队列分别为0.79、0.75、0.73,校准曲线和DCA支持其临床相关性。

要点

  • 列线图整合Rad-score、pN和pT预测II/III期结直肠腺癌无病生存,训练队列1、2、3年AUC为0.78、0.80、0.86。
  • 验证队列1、2、3年AUC分别为0.79、0.75、0.73,校准曲线和DCA affirmed临床相关性。
  • 该列线图可能有助于预后分层和临床决策,但为回顾性单中心研究,需进一步验证。

核心结论

  • 基于18F-FDG PET/CT的影像组学列线图(含Rad-score、pN、pT)能有效预测II/III期结直肠腺癌肿瘤复发,显著增强预后分层,研究结果提示该列线图可能作为临床决策的指导以改善患者结局。

研究设计与样本

  • 回顾性分析纳入2011年7月至2021年7月中山大学附属第六医院的332例II/III期结直肠腺癌患者,采用18F-FDG PET/CT评估影像组学特征和临床病理特征;通过单因素Cox回归、LASSO Cox和多因素Cox回归筛选复发相关影像组学特征,使用加权Rad-score和独立危险因素构建列线图;评估采用时间依赖ROC曲线、校准曲线和DCA。

诊断标准与关键数值

  • 列线图包含Rad-score、pN和pT;训练队列1年、2年、3年AUC分别为0.78、0.80、0.86;验证队列1年、2年、3年AUC分别为0.79、0.75、0.73;校准曲线和DCA affirmed临床相关性。

临床应用与阅片要点

  • 作者认为该列线图可能作为临床决策的指导以改善患者结局;原文未报告具体的阅片阈值或报告要点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study aimed to establish a clinical nomogram model based on a radiomics signatures derived from 18F-fluorodeoxyglucose positron-emission tomography (18F-FDG PET/CT) and clinical parameters to predict disease-free survival (DFS) in patients with stage II/III colorectal adenocarcinoma. Understanding and predicting DFS in these patients is key to optimizing treatment strategies.

METHODS: A retrospective analysis included 332 cases from July 2011 to July 2021 at The Sixth Affiliated Hospital, Sun Yat-sen University, with PET/CT assessing radiomics features and clinicopathological features. Univariate Cox regression, the least absolute shrinkage and selection operator (LASSO) Cox, and multivariable Cox regression identified recurrence-related radiomics features. We used a weighted radiomics score (Rad-score) and independent risk factors to construct a nomogram. Evaluation involved time-dependent receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA).

RESULTS: The nomogram, incorporating Rad-score, pN, and pT demonstrated robust predictive ability for DFS in stage II/III colorectal adenocarcinoma. Training cohort areas under the curve (AUCs) were 0.78, 0.80, and 0.86 at 1, 2, and 3 years, respectively, and validation cohort AUCs were 0.79, 0.75, and 0.73. DCA and calibration curves affirmed the nomogram's clinical relevance.

CONCLUSION: The 18F-FDG PET/CT based radiomics nomogram, including Rad-score, pN, and pT, effectively predicted tumor recurrence in stage II/III colorectal adenocarcinoma, significantly enhancing prognostic stratification. Our findings highlight the potential of this nomogram as a guide for clinical decision making to improve patient outcomes.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Wang B, Hu T, Shen R, et al. A 18F-FDG PET/CT based radiomics nomogram for predicting disease-free survival in stage II/III colorectal adenocarcinoma. Abdom Radiol (NY). 2024. PMID: 39096393. doi:10.1007/s00261-024-04515-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。